Effects of pretreatment with verapamil on the toxicokinetics of soman in rabbits and distribution in mouse brain and diaphragm

Toxicol Lett. 2003 Mar 3;138(3):227-33. doi: 10.1016/s0378-4274(02)00415-0.

Abstract

The effects of verapamil on the elimination of soman in rabbit blood and distribution in mouse brain and diaphragm by determining the concentration of P(-)soman using the chirasil capillary gas chromatographic analysis method were studied in order to study the effects of verapamil on the metabolic detoxification of soman. Verapamil (10 mg kg(-1), im, 30 min before soman administration) could significantly reduce the concentration of P(-)soman in rabbit blood at 15, 60, 90, 120, 180 and 240 s after soman injection (43.2 microg kg(-1), iv) as compared to soman-treated control animal respectively. Toxicokinetics parameters showed verapamil could increase clearance rate from 20.8+/-1.51 to 44.3+/-7.0 ml kg(-1)s(-1) and reduce AUC of P(-)soman from 2.08+/-0.151 to 0.996+/-0.172 mg s l(-1). For experiments in mice, verapamil could reduce the concentration P(-)soman in diaphragm from 74.7, 70.5, 88.7 to 41.1, 39.0, 49.3 ng g(-1) at the time of 30, 90, 120 s after intoxication of soman subcutaneously vs. soman control respectively, but it had no influence on the concentration of free P(-)soman in brain. Verapamil accelerated the elimination of P(-)soman in the rabbits blood and reduced the distribution of P(-)soman in the mouse diaphragm.

MeSH terms

  • Animals
  • Area Under Curve
  • Brain / drug effects
  • Brain / metabolism
  • Calcium Channel Blockers / pharmacology
  • Cholinesterase Inhibitors / pharmacokinetics*
  • Cholinesterase Inhibitors / toxicity
  • Chromatography, Gas
  • Diaphragm / drug effects
  • Diaphragm / metabolism
  • Half-Life
  • Inactivation, Metabolic
  • Mice
  • Rabbits
  • Soman / antagonists & inhibitors
  • Soman / blood
  • Soman / pharmacokinetics*
  • Soman / toxicity
  • Stereoisomerism
  • Vasodilator Agents / pharmacology*
  • Verapamil / pharmacology*

Substances

  • Calcium Channel Blockers
  • Cholinesterase Inhibitors
  • Vasodilator Agents
  • Soman
  • Verapamil